Mallanox medication

Mallanox is a popular pharmaceutical brand primarily known for its products targeting gastrointestinal issues, specifically formulated for the treatment of diarrhea and related digestive discomfort. It is manufactured and marketed by Amoun Pharmaceutical Company, one of the leading drug manufacturers in the Egyptian market.

Originally developed in Egypt, the brand has built a significant reputation for reliability in the Middle East and North Africa (MENA) region. While Amoun Pharmaceutical remains the company of origin, it has seen several changes in ultimate ownership. Since 2021, the brand has been under the ultimate ownership of ADQ, the Abu Dhabi-based investment and holding company, which acquired Amoun to expand its healthcare and life sciences portfolio. This transition underscores the brand's integration into a larger multinational healthcare strategy focused on the MENA market.